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ABSTRACT
Background: Gastroesophageal reflux (GER) is a common clinical pathology
detected in childhood. Bile acids (BAs) are present in reflux and cause various
pathologies in the esophagus, the larynx, and the lungs.
Objective: We aimed to show if aminoguanidine (AG) contributes to the
iochemical and histopathologic treatment of experimental aspiration pneumonitis
nduced by BAs.
Methods: Twenty-eight female Sprague Dawley rats were used. There were 4
groups in the study: (1) group aspirated with 0.9% saline (n 7), (2) group aspirated
with 0.9% saline and treated with AG (n  7), (3) group aspirated with a solution
of 10 mg/kg taurocholic acid and 5 mg/kg taurochenodeoxycholate (n  7), and (4)
group aspirated with BA and treated with AG (n  7). The saline and BA solutions
were administered as 1 mL/kg intratracheally. The AG was administered intraperi-
toneally twice a day at a 150 mg/kg dose for 7 days. The different histopathologic and
biochemical parameters were analyzed.
Results: Clara cell protein 16 and malondialdehyde levels were found to be
significantly higher in the BA group than in the group where saline was administered;
however, they were significantly lower in the BA AG group than in the BA group.
The total superoxide dismutase activity decreased significantly in the BA group
compared with the group where saline was administered. A significant increase in
superoxide dismutase activity was observed in the BA  AG group when compared
ith the group where only BA was administered. When the group where BA was
dministered solely was compared with the group where saline was administered,
eribronchial inflammatory cell infiltration, alveolar septal infiltration, alveolar his-
iocytes, interstitial fibrosis, and granuloma were significantly higher in the BA group
han in the saline group. When the BA  AG group was compared with the BA
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Current Therapeutic Researchgroup, peribronchial inflammatory cell infiltration, alveolar septal infiltration, alve-
olar histiocytes, interstitial fibrosis, and granuloma were found to be significantly
lower.
Conclusions: Oxidant stress increases and antioxidant capacity decreases in
pneumonitis induced by BAs. AG administration as an antioxidant helps in recovery,
both biochemically and histopathologically. Consequently, AG seems to be an alter-
native that should be considered in a conservative approach to treating aspiration
pneumonitis. (Curr Ther Res Clin Exp. 2012;73:207–219) © 2012 Elsevier HS
Journals, Inc. All rights reserved.
Key words: aminoguanidine, aspiration pneumonitis, bile acids, CC-16, gas-
troesophageal reflux.
INTRODUCTION
The reflux of duodenogastric content into the esophagus and the airway is defined as
gastroesophageal reflux (GER) and is a common clinical pathology detected in
childhood. Aspiration is a condition in which the gastric or duodenal content reaches
the larynx due to reflux and passes under the vocal cords, causing morbidity and
mortality, as well as severe complications.1,2
Although GER is a common disease in infants and children, the nature of its
evelopment is not completely known. Many children experience reflux symptoms
ntil they are aged 12 to 18 years. Treatment is not required in most cases; however,
t is essential when symptoms become pathologic and when related complications
evelop.3 One of GER’s most important complications is the aspiration of reflux
ontent, resulting in pulmonary complications that may range from slight symptoms
o severe pulmonary damage.1 Persistent aspirations weaken one’s general health and
ause serious morbidity and mortality. Treatment varies from simple conservative
pproaches to complex surgical interventions.
Although reflux content is more acidic in GER, studies have shown that bile acids
BAs) are also present in reflux content and cause various pathologies in the esoph-
gus, the larynx, and the lungs.4 However, it is still not clear how BAs cause damage
in terms of frequency and mechanisms.
BA-induced pulmonary pathologies may be seen in other conditions besides GER.
For instance, the aspiration of BAs in particular (and not the aspiration of gastric
acids) is an important factor in the development of bronchiolitis obliterans syndrome
after lung transplantation.5 In a study conducted by D’Ovidio et al,6 the quantity of
A in bronchoalveolar lavage fluid was examined in 120 post-transplant patients, and
t was found to be positive in 17%. BA was also found more in early bronchiolitis
bliterans syndrome patients.
Aminoguanidine (AG) is known as an antioxidant and a free-radical trapper.7
Studies have shown that AG prevents cellular damage and a decrease in antioxidant
enzymes in rats.7,8 Eroglu et al9 showed that AG increases enzyme capacity and
rotects rats from radiation-induced lung toxicity. AG has also been used to prevent
r treat nephropathy, retinopathy, and neuropathy.
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R. Karli et al.The objective of our study was to determine if AG contributes to the biochemical
nd histopathologic treatment of experimental aspiration pneumonitis induced by
As. For this purpose, Clara cell protein 16 (CC-16), malondialdehyde (MDA),
itrate/nitrite quantities, glutathione peroxidase (GSH-Px), total superoxide dismu-
ase (SOD) activities, and histopathologic parameters were analyzed.
MATERIALS AND METHODS
Experimental Animals and Study Groups
We obtained approval of the Animal Experiments Local Ethical Committee of
ndokuz Mayis University, and the study was done in accordance with Directive
6/609/EEC on the protection of animals used for scientific purposes. The rats were
btained from the Laboratory Animals Research and Application Centre of Ondokuz
ayis University, where the surgical section of the study and the drug applications
ere performed.
Twenty-eight female Sprague Dawley rats were used. Their weights ranged be-
ween 220 and 280 g. The environment where the cages were kept was about 50%
o 55% humidity, with a temperature of 20°C to 24°C. The rats were kept in
aylight for 12 hours and in the dark for another 12 hours. Sufficient food and water
as provided, except for 12 hours before the surgical procedure, when no food or
ater was given.
The main groups in the study were: (1) group aspirated with 0.9% saline (n  7),
2) group aspirated with 0.9% saline and treated with AG (n  7), (3) group
spirated with a solution of 10 mg/kg taurocholic acid and 5 mg/kg taurochenode-
xycholate (a BA) (n  7), and (4) group aspirated with a solution of 10 mg/kg
aurocholic acid and 5 mg/kg taurochenodeoxycholate and treated with AG (n  7).
The saline and BA solutions were administered as 1 mL/kg intratracheally. One
ay after the rats were aspirated with BA, AG was administered intraperitoneally
wice a day in a 150 mg/kg dose for 7 days.10
Surgical Procedure
The rats were anesthetized with 100 mg/kg ketamine hydrochloride and 10 mg/kg
ylazine applied intraperitoneally, and they respirated spontaneously during the
urgical procedure. A horizontal incision was made between the sternal incisura and
he thyroid cartilage. The strep muscles were dispensed by passing the cutaneous and
ubcutaneous tissues, and the trachea was revealed. BA was administered into the
racheal lumen using a 20-gauge 1-mL tuberculin injector between the second and
hird tracheal rings.
Sample Collection
The rats were killed after undergoing the AG treatment for 7 days. Although part
f the removed lung tissue was used for histopathologic examination, other parts were
sed for the analysis of the biochemical parameters. A few vertical incisions were
hrown on bronchioles to fix the pulmonary tissue samples removed for histopatho-
ogic examination, and they were kept in a 10% buffered and neutralized formalin at
0°C to 25°C for 48 hours. The tissue samples removed for biochemical analysis were
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Current Therapeutic Researchkept at 80°C until the analysis was performed. Blood samples were collected in
tubes without anticoagulants. The tubes were centrifuged at 3000  g for 10
minutes, and the serum samples were kept at 80°C until they were analyzed.
Histopathologic Examination
The pulmonary tissue samples were dehydrated in alcohol and embedded in
araffin. Sections of 4 mm were prepared, deparaffinized, and stained with hematox-
lin and eosin. The pulmonary tissues were examined randomly by a pathologist with
light microscope under blind conditions. The 4-scale system developed by Takil et
l11 was used with modifications for peribronchial inflammatory cell infiltration
(PICI), alveolar septal infiltration (ASI), alveolar exudate (AEx), interstitial fibrosis
(IF), alveolar histiocytes (AH), and granuloma (GR) (Table I).
Biochemical Analysis
Before analyzing the biochemical parameters, the serum and tissue samples were
llowed to thaw by themselves. The pulmonary tissues were homogenized by 0.50 mL
riton X-100 (Dow Chemical Company, Midland, Michigan) containing ice-cold
ris-hydrogen chloride buffer (50 mM, pH 7.4).
uantitative Protein Assay
To calculate MDA, nitric oxide (NO) quantities, SOD, and GSH-Px activities, a
rotein assay was performed using the Lowry method.12 The color that resulted from
the study was measured spectrophotometrically on a 700 nm wavelength. The protein
quantity of the samples was assayed with bovine serum albumin used as a standard.
CC-16
The quantity of CC-16 was detected in the serum using the enzyme-linked
Table I. The 4-score scale used in histopathologic analysis.
0 1 2 3
ICI No Prominent germinal centers
of lymphoid follicles
Infiltration between
lymphoid follicles
Confluent bandlike
form
ASI No Minimal Moderate Severe, impending of
lumen
AEx No Focal In multiple alveoli Prominent, widespread
IF No Focal, minimal Focal, prominent
fibrous
thickening
Widespread, prominent
fibrous thickening
AH No Scattered in a few alveoli Forming clusters in
alveolar spaces
Filling the alveolar
spaces
GR No Rare, micro Focal, well formed Confluent, large
AEx  alveolar exudate; AH  alveolar histiocytes; ASI  alveolar septal infiltration; GR  granuloma;
IF  interstitial fibrosis; PICI  peribronchial inflammatory cell infiltration.immunosorbent assay method according to the instructions of the manufacturer (Uscn
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R. Karli et al.Life Science Inc, Wuhan, China). The color was read on a microplate reader with a
wavelength of 450 nm (Serial No. 60200045; Sunrise-Basic Tecan, Grödig, Austria).
The results were given in picograms per milliliter via the standard graphic.
MDA
The MDA quantity in the pulmonary tissue samples was analyzed using the
method of Draper et al.13 The color that resulted after the reactions was read on a
wavelength of 532 nm. The extinction coefficient of the MDA-thiobarbituric acid
complex (1.56  105 cm/M) was used to calculate the results, which were given in
anomoles per gram protein.
SH-Px
The GSH-Px activity in the pulmonary tissue was analyzed using the method
eveloped by Paglia et al.14 In this method, GSH-Px converts the reduced glutathi-
ne into oxidized glutathione when hydrogen peroxide is present. The oxidized
lutathione is reduced into glutathione again when glutathione reductase and re-
uced nicotinamide adenine dinucleotide phosphate are present, and the GSH-Px
ctivity is measured by determining the quantity of nicotinamide adenine dinucle-
tide phosphate consumed during this process. The absorbance of nicotinamide
denine dinucleotide phosphate at 340 nm was recorded, and the results were
alculated by considering the change in the absorbance difference by time. The results
ere given in units per gram protein.
OD
The SOD activity in the pulmonary tissue was analyzed according to the method
stablished by Sun et al15 and modified by Durak et al.16 This test depends on the
principle of formazon creation by reducing nitro blue tetrazolium via the super oxide
radical produced by the xanthine/xanthine oxidase system. The SOD enzyme prevents
the coloration of nitro blue tetrazolium by dismutasing superoxide radicals in the
environment. The absorbance of the samples against distilled water were read at 560
nm. The results were given in units per milligram protein.
Measurement of NO Quantity
The quantity of NO was detected indirectly by measuring the nitrate and nitrite
uantities in the pulmonary tissue.17 The samples were deproteinized by using
omogy’s reactive. Nitrate, which was present in the samples with cadmium pieces,
as reduced into nitrite. The color that appeared as a result of the reaction of the
aphthylethylenediamine and sulfanilamide mixture with nitrite was read at a wave-
ength of 545 nm. The results obtained by using the standard graphic were given in
icromoles per gram protein.
Statistical Method
Data analysis was performed with SPSS statistical software (version 15.0, 2006;
BM, Armonk, New York), resulting in averages and standard deviations. An inde-
endent sample t test was used for the comparison of CC-16 between the groups. The
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Current Therapeutic ResearchMann-Whitney U test was used for the comparison of the other biochemical and
histopathologic parameters between the groups, and P  0.05 was accepted as
ignificant. The graphics used to present the biochemical parameters were created
sing Microsoft Office Excel 2007 (Miscrosoft Corp, Redmond, Washington).
RESULTS
Biochemical Parameters
CC-16 was found to be significantly higher in the BA group than in the group
here saline was administered (P  0.002). It was found to be significantly lower in
he BA  AG group than in the BA group (P  0.001) (Figure 1).
MDA quantities were analyzed to show oxidative stress levels, and nitrate/nitrite
uantities were analyzed to show nitrosative stress. The quantity of MDA in the
roup where BA was administered was significantly higher than in the saline group;
owever, no significant change was observed in the nitrate/nitrite quantities (P 
.017 and P  0.406, respectively). Although MDA was significantly lower in the
A  AG group than in the BA group, no significant change was detected in the
itrate/nitrite quantities (P  0.003 and P  0.608, respectively) (Figure 2).
The SOD activity that we analyzed to observe the changes in antioxidant capacity
ecreased significantly in the BA group compared with the group where saline was
dministered, although no significant change was detected in the GSH-Px activity
P  0.003 and P  0.564, respectively). Whereas a significant increase in SOD
ctivity was observed in the BA  AG group when compared with the group where
A was administered, no significant change was detected in GSH-Px activity (P 
180
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Saline Saline+AG BA BA+AG
CC-16
69.41 (8.90)
71.22 (11.04)
170.7 (53.06)*
73.71 (16.44)†
Figure 1. Comparison of Clara cell protein 16 (CC-16) between groups. AG  aminogua-
nidine; BA  bile acids. *P  0.002, compared with the saline group; †P 
0.001, compared with the BA group..002 and P  0.748, respectively) (Figure 3).
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R. Karli et al.Results of the Histopathologic Analysis
When the group where BA was administered solely was compared with the group
here saline was administered, PICI (P 0.001), ASI (P 0.001), AH (P 0.025),
F (P  0.001), and GR (P  0.003) were significantly higher than in the saline
roup. However, no difference was detected for AEx (P  0.317). When the group
here BA  AG were administered was compared with the group where BA was
dministered solely, PICI (P  0.001), ASI (P  0.001), AH (P  0.016), IF (P 
.001), and GR (P  0.003) were found to be significantly lower. No significant
ifference was present between both groups for AEx (P  1.000) (see Table II and
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B
Figure 2. Comparison of (A) nitric oxide (NO) and (B) malondialdehyde (MDA) between
groups. AG  aminoguanidine; BA  bile acids. *P  0.017, compared with the
saline group; †P  0.003, compared with the BA group.igure 4).
213
Current Therapeutic ResearchDISCUSSION
We showed that BAs have increased oxidative stress than nitrosative stress and
decreased antioxidant capacity in the lungs. There is an increase in CC-16 levels,
together with pulmonary damage. When AG was administered, the oxidative
stress and CC-16 quantity induced by the BAs decreased, and antioxidant
capacity increased. Furthermore, a decrease was monitored in the histopathologic
changes caused by BAs when AG was administered. AG was administered for
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Figure 3. Comparison of quantities of (A) superoxide dismutase (SOD) and (B) glutathione
peroxidase (GSH-Px) between groups. AG  aminoguanidine; BA  bile acids.
*P 0.003, compared with the saline group; †P 0.002, compared with the BA
group.therapeutic purposes 1 day after the intratracheal aspiration of BAs, and applied
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R. Karli et al.for 7 days. Thus, we determined that AG effectively recovered the damage caused
by BAs.
Chronic aspiration with recurrent episodes, which is very common in pediatric
patients, significantly decreases quality of life and is a very important cause of
morbidity and mortality.18 BAs, which are in the reflux content and aspirated
materials, may cause various pathologies in the esophagus,4,19 larynx,20 and lungs.21
Tutar et al20 compared cases of laryngeal cancers with cases of benign laryngeal lesions
and found the total BA quantity to be higher in laryngeal cancer tissue and
hypopharyngeal tissue, although no difference in blood levels was detected in either
group. Another study that investigated the effects of BAs showed that laryngeal
mucosa and esophagus mucosa have different reactions.22 The same study showed that
BA causes damage in both acidic and nonacidic environments, and that such damage
has been resistant to treatments.22 All of these studies indicated that BAs in reflux
ontent affects the larynx and causes different pathologies due to aspiration into the
ungs.
Many options exist for the treatment of persistent aspirations, ranging from simple
onservative approaches to complex surgical interventions. The main conservative
reatment strategies are nasogastric feeding or gastrostomy tube application; paren-
eral hyperalimentation; swallowing rehabilitation; changing the feeding regimen;
ositioning the head; using antiemetic and antireflux drugs; and other drug treat-
ents, including the use of antibiotics.23 Surgical interventions vary. Many surgical
rocedures, from simple approaches to total laryngectomy, have been defined and
pplied to prevent aspiration. All of the surgical approaches have different advantages
nd disadvantages; however, there is no gold standard method.23 All of those studies
uggest that new treatment options should be used to overcome resistance in the
reatment of the damage, which may be due to BA. AG, which was used in our study,
Table II. Results of the histopathologic analysis.
Mean (SD)
Saline Saline  AG BA BA  AG
ICI 0.286 (0.488) 0.429 (0.535) 2.286 (0.488)* 0.571 (0.535)†
ASI 0.429 (0.535) 0.286 (0.488) 2.857 (0.378)* 0.571 (0.535)†
AEx 0.000 (0.000) 0.000 (0.000) 0.143 (0.378) 0.143 (0.378)
IF 0.429 (0.535) 0.714 (0.488) 2.857 (0.378)* 1.143 (0.378)†
AH 1.000 (0.000) 0.857 (0.378) 1.857 (0.900)* 0.714 (0.488)†
GR 0.286 (0.488) 0.286 (0.488) 2.000 (0.817)* 0.286 (0.488)†
AEx  alveolar exudate; AG  aminoguanidine; AH  alveolar histiocytes; ASI  alveolar septal
infiltration; IF  interstitial fibrosis; GR  granuloma; PICI  peribronchial inflammatory cell infiltration.
*P  0.05, compared with saline group; † P  .05, compared with the BA group.s an alternative that may be useful.
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cute neutrophilic inflammatory response in the respiratory tract epithelium appear
fter the administration of gastric acid to the lungs.24 Proteolytic enzymes; reactive
oxygen/nitrogen species; cytokines; and chemokines, which are secreted from neut-
rophiles, cause damage in the endothelial cells and alveoli.25 The damage causes
disruption of the pulmonary microvascular integrity and extravasation of fluid and
protein into the airway and alveoli.24,26 A decrease in the secretion of matrix
metalloproteinase and elastase decreases lung diseases.27 In acute respiratory distress
syndrome, there is a decrease in the capacity of the antioxidant system at the
beginning and when the disease progresses, and lipid peroxidation increases at the
beginning of the disease and when the disease progresses.28,29 In our study, MDA was
significantly higher in the group where BA was administered than in the saline group.
This increase in MDA may be caused by the reactive oxygen types secreted from
neutrophiles that affect lipid molecules. Higher PICI and ASI parameters in the
Figure 4. Images of histopathologic analysis (hematoxylin-eosin stain  40). (A) Saline
group, (B) saline  aminoguanidine group, (C) bile acid group, and (D) bile
acid  aminoguanidine group. Almost normal lung parenchyma is monitored in
A, B, and D similar to each other. There is an inflammatory cell infiltration in the
peribronchial zones (star). The interalveolar zones are natural in general; slight
inflammatory cell infiltration may be monitored in small focal zones. Significant
inflammatory cell infiltration, thickening in interalveolar zones, and diffuse in-
flammation are observed in the peribronchial zones in the bile acid group.histopathologic analysis in the group where BA was administered support this result.
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oxidative stress is more effective than nitrosative stress on the damage induced by
BAs. Furthermore, a decrease in antioxidant enzyme capacity was monitored in the
lung tissue. A significant decrease in SOD activity was present in the group where BA
was administered. A decrease in the antioxidant capacity or the direct effect of BAs
may contribute to an increase in the oxidative stress in the environment.
Our study shows that AG, which was administered with BA, caused significant
recovery, both biochemically and histopathologically. When the group where BA 
AG were administered was compared with the group where BA was administered, a
decrease in MDA, an increase in SOD activity, and a decrease in CC-16 were observed.
When the histopathologic parameters were reviewed, significant decreases in PICI,
ASI, IF, AH, and GR were detected. We should particularly emphasize that the
administration of AG was started 1 day after the aspiration of BAs, and it was applied
for 7 days. These results show that AG is useful on biochemical and tissue levels and
may be an effective treatment option.
There is no good marker that may be used for diagnosis in aspiration pneumonia/
pneumonitis. The most appropriate markers are tumor necrosis factor- and mono-
yte chemoattractant protein-1 within the first 6 hours after acid aspiration and
ytokine-induced neutrophil chemoattractant-1 within the first 24 hours. For small
onacidifed particles, macrophage inflammatory protein-2 is the marker within the
rst 6 hours and tumor necrosis factor-alpha for the first 24 hours. Whereas cytokine-
nduced neutrophil chemoattractant-1 is the marker for combined hydrochloric acid
lus small nonacidifed particles for the first 6 hours, it is monocyte chemoattractant
rotein-1 within the first 24 hours.30 CC-16 quantities were analyzed in our study
with the thought that it might be a marker, and CC-16 was higher in the BA group
and lower in the BA  AG group. These results show that CC-16 may be used to
detect damage that has occurred 1 week after the aspiration and to monitor the
treatment response.
Oxidant stress increases and antioxidant capacity decreases in pneumonitis induced
by BAs. AG administration as an antioxidant helps in recovery, both biochemically
and histopathologically.
CONCLUSIONS
AG seems to be an alternative that should be considered in a conservative approach
to treating aspiration pneumonitis. When clinical studies are performed on human
subjects, the therapeutic efficacy of AG on aspiration pneumonitis should be pre-
sented more clearly.
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